OK , so would have thought a TH 1st week of November? if LCT only updated in September and state completed in October? My pick is there will be delays..... plus LCT will want to be diligent. I'm locked in for the ride now, will re-asses after the AGM depending on how much detail on the Business is announced, I see a lot of promo for the USA company with the Dyskinesia drug ,, yesterday on their market update pushed the SP to 23 USD, they are only dealing with the Dyskinesia not Parkinsons itself. They promote themselves and the company and just picked up a $100m funding partner and already have over $100m in the Bank.
It mentions 700,000 Americans on Levodopa at a cost annually of $20,000USD. Do the Math....
LCT Price at posting:
20.0¢ Sentiment: Buy Disclosure: Held
